Search results
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be...
Motley Fool via Yahoo Finance· 10 hours agoNot only is the company losing money hand over fist, but its revenue is actually declining, mainly...
Asthma Attack: Allergies, Rising Costs Impacting Patients
WebMD· 6 days agoAcross the U.S., warmer days have beckoned an earlier spring, and with that, an earlier pollen season and worse seasonal allergies. Pair that with an ongoing respiratory virus season – particularly ...
Peripheral Neuropathy Market is Expected to Hit USD 7.95 Billion by 2031
Digital Journal· 4 days agoAccording to SNS Insider, Peripheral Neuropathy Market is projected to reach USD 7.95 Billion by...
Scientists Discover New Antibiotic Class Effective Against Drug-Resistant Bacteria
SciTechDaily· 20 hours agoResearchers at Uppsala University have discovered a new class of antibiotics with potent activity...
23andMe CEO plans to take company private
MedTech Dive via Yahoo Finance· 5 days agoWojcicki's proposal as the new most likely outcome which should be welcomed by investors.” 23andMe has faced financial pressure as sales of DNA tests...
Nelson Peltz Got Crushed by Disney. Can He Recover?
The Wall Street Journal· 6 days agoNelson Peltz’s proxy fight at Disney had the potential to help turn around his hedge fund after a tumultuous stretch. Instead, the activist investor’s...
Asthma Inhaler Chaos Leaves Us Doctors and the Children We Treat Out of Breath
US News & World Report· 5 days agoOn Jan. 10, Laura Goldstein went to her local Massachusetts pharmacy to fill her 4-year-old son’s prescription for Flovent, the go-to preventive asthma inhaler prescribed by pediatricians for ...
Daschle, Yoder ink new clients
Politico· 7 days agoShe’s signed one new client as well, according to disclosure filings: the drugmaker GlaxoSmithKline. Happy Tuesday and welcome to PI. Send tips: [email protected]. And be ...
Middlesex chief executive: 'Why could Lord's not become like the San Siro in Milan?'
ESPN· 2 days agoMiddlesex are weighing up their options for a future away from Lord's, their county home for the...
A Look at Trabectedin Monotherapy for Recurrent Ovarian Cancer
MedPage Today· 6 days agoTreatment with trabectedin monotherapy did not extend median overall survival (OS) in a prospective,...